Skip to content
  • BiotechReality JobFinder
  • Market Analysis
  • Publish on BiotechReality
  • linkedin
  • facebook
  • instagram
  • twitter
BiotechReality

BiotechReality - Information Intelligence System for Biopharma

  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
Popular
#FDA #Eli Lilly and Company #Johnson&Johnson #Phase 3 Trial #FDA Approval #Clinical Data #Hoffmann-La Roche #Pfizer
Disease Biology Molecular Biology

Mitochondrial protein synthesis disruption in Alzheimer’s disease can be caused by RNA modification

  • By Journal Updates
  • 7 May 2024
protein synthesis

Methylation of mRNA impairs the brain’s energy supply by interfering with the synthesis of ND5, a subunit of complex I of the respiratory chain.

Tagged Alzheimer's, mitochondria, Protein Synthesis
Science News

Researchers found evidence that orangutan treats wounds with pain-relieving plant

  • By Achuth B S
  • 5 May 2024
orangutan treat wound

The great apes, who are the closest living ancestors of humans, are known to apply plant material topically to relieve painful muscles and to consume certain plants to cure parasite infections.

Tagged Orangutan, Self-Treatment
Genetics Disease Biology News

Progression of amyotrophic lateral sclerosis (ALS) can be slowed down by a new gene therapy

  • By Journal Updates
  • 4 May 2024
amyotrophic lateral sclerosis

Researchers at Umeå University demonstrate that a novel gene treatment has significantly slowed down the disease development in a patient with an extremely severe type of ALS illness.

Tagged Amyotrophic Lateral Sclerosis, Gene Therapy
Biotechnology

Advanced heart regenerative therapy using stem cell-derived heart muscle cells

  • By Editor's Desk
  • 1 May 2024
muscle cells in the heart

Human induced pluripotent stem cells (HiPSCs) represent one exciting approach that is gradually gaining popularity in the field of regenerative cardiac treatment.

Tagged Heart Muscle, Regenerative Therapy
Genomics News Technology

Single Cell Atlas; a pioneer for biomedical research

  • By Editor's Desk
  • 29 April 2024
Single Cell Atlas

The goal is to produce an essential instrument that will assist researchers globally in understanding more about human health and illness.

Tagged Biomedical Research, Genome Biology, Single Cell Atlas
Cell Biology Research

Researchers created artificial cells that mimic the original cells

  • By Journal Updates
  • 27 April 2024
artificial cells

The first-in-field achievement has ramifications for medicine delivery systems, diagnostic tools, and regenerative medicine initiatives.

Tagged Artificial Cells, Cells
Diagnostic Tests News

Prostate cancer can be detected by a urine test

  • By Editor's Desk
  • 24 April 2024
urine test for prostate cancer

The test, which examines 18 genes, was created especially to identify malignancies that require rapid treatment as opposed to those that grow slowly.

Tagged Prostate Cancer, Urine Test
Cancer Immunology

A new way to boost the immune cells to fight against cancer cells

  • By Editor's Desk
  • 22 April 2024
immune cell therapy for cancer

To increase the efficacy of treatment, scientists from Virginia Tech’s College of Engineering have created a novel cancer immunotherapy that targets cancer-killing cytokines where they are found in tumours.

Tagged Cancer, Immunotherapy
Research Microbiology

Research: Discovery of a new class of antimicrobials in soil bacteria

  • By Journal Updates
  • 20 April 2024
soil bacteria

For almost a century, researchers have mined Streptomyces for antibiotics; nevertheless, the recently discovered umbrella toxin went unnoticed.

Tagged Antimicrobials, Soil Bacteria
Healthcare & Pharmaceuticals News

FDA-approved epilepsy drug prevents brain tumors in mice with NF1

  • By Journal Updates
  • 18 April 2024
epilepsy brain

Research establishes foundation for clinical experiment targeted at averting brain tumours in kids with NF1.

Tagged Brain Tumors, Epilepsy, FDA

Posts navigation

← Older Posts
→ Newer Posts
Advertisement

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Autoimmune Diseases
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biologics
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • Cell Biology
  • Clinical Data
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • CRO
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Legal and Patent Affairs
  • Life Sciences
  • Machine Learning
  • Manufacturing
  • Medical Devices
  • Mental Health
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Rare Diseases
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs

Discover More

EBGLYSS Durable Efficacy: Lilly Reports Landmark 4-Year Results for Atopic Dermatitis
Clinical Trials Clinical Data Healthcare & Pharmaceuticals News

EBGLYSS Durable Efficacy: Lilly Reports Landmark 4-Year Results for Atopic Dermatitis

27 March 202628 March 2026
Clinical Trials & Data Desk
Pfizer and Valneva Announce Strong Efficacy for Lyme Disease Vaccine Candidate
Clinical Trials Clinical Data News Vaccines

Pfizer and Valneva Announce Strong Efficacy for Lyme Disease Vaccine Candidate

26 March 202626 March 2026
Clinical Trials & Data Desk
Novo Nordisk’s UBT251 Triple Agonist Achieves Landmark 2.16% HbA1c Reduction in Type 2 Diabetes Phase 2 Trial
Clinical Trials Clinical Data Diabetes News

Novo Nordisk’s UBT251 Triple Agonist Achieves Landmark 2.16% HbA1c Reduction in Type 2 Diabetes Phase 2 Trial

25 March 202625 March 2026
Clinical Trials & Data Desk
Novartis Immunology Data at AAD 2026: Rhapsido and Cosentyx Results
Autoimmune Diseases Clinical Data Clinical Trials Healthcare & Pharmaceuticals News

Novartis Immunology Data at AAD 2026: Rhapsido and Cosentyx Results

24 March 202624 March 2026
Clinical Trials & Data Desk
GSK Secures Japan Orphan Drug Designation for Risvutatug Rezetecan in Small-Cell Lung Cancer
News Clinical Data Oncology Regulatory

GSK Secures Japan Orphan Drug Designation for Risvutatug Rezetecan in Small-Cell Lung Cancer

23 March 202623 March 2026
Clinical Trials & Data Desk
Pfizer’s Talzenna + Xtandi Delivers Proven rPFS Breakthrough in HRR-Mutated mCSPC
Clinical Trials Healthcare & Pharmaceuticals News

Pfizer’s Talzenna + Xtandi Delivers Proven rPFS Breakthrough in HRR-Mutated mCSPC

20 March 202620 March 2026
Clinical Trials & Data Desk
Advertisement
BiotechReality JobFinder

  • Regulatory Specialist
    28 March 2026
  • Medical Device Associate Consultant
    26 March 2026
  • Manufacturing Quality Assurance Engineer
    26 March 2026
  • Product Manager – Immunoassay
    26 March 2026
  • Quality Specialist
    24 March 2026

BiotechReality Shots Weekly News letter

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2026
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
  • Market Analysis
  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
  • Newsletters
  • linkedin
  • facebook
  • instagram
  • twitter
We use cookies to improve your browsing experience, deliver personalized content and ads, and analyze our traffic. By clicking “Accept All”, you consent to our use of cookies.